The global nonvascular interventional radiology device market is projected to grow from USD 27.6 billion in 2024 to USD 44.6 billion by 2034, reflecting a compound annual growth rate (CAGR) of 4.9% over the forecast period. The growth is being driven by rapid advancements in imaging technologies and an increased emphasis on improving diagnostic precision and efficacy.
Technological advancements in imaging infrastructure are playing a pivotal role in shaping the nonvascular interventional radiology device market. These improvements are designed to enhance the quality of diagnosis, thereby fueling the demand for more sophisticated equipment. The evolution of imaging technology, particularly in orthopedic imaging, is enabling healthcare providers to offer more precise and accurate diagnosis, reducing the need for invasive procedures. As a result, the market for nonvascular interventional radiology devices is poised for steady growth.
The emphasis on enhancing diagnostic efficiency is leading to the introduction of new technologies and modernized devices. These advances are helping healthcare providers identify conditions earlier and with greater accuracy, enabling better patient outcomes. With ongoing developments in orthopedic imaging equipment and an increasing focus on technological infrastructure, market players have a significant opportunity to capitalize on the growing demand for nonvascular interventional radiology devices.
A Full Report Overview – https://www.futuremarketinsights.com/reports/nonvascular-interventional-radiology-devices-market
Key Takeaways:
- The global nonvascular interventional radiology device market is projected to grow from USD 27.6 billion in 2024 to USD 44.6 billion by 2034, at a CAGR of 4.9%.
- The market’s growth is being driven by rapid advancements in imaging technologies aimed at improving diagnostic accuracy and efficacy.
- Modernized orthopedic imaging equipment and increased focus on technological infrastructure are key factors propelling the market’s growth.
- Demand for new, precision-driven diagnostic tools offers growth opportunities for manufacturers of nonvascular interventional radiology devices.
As technological innovations continue to shape the future of imaging and diagnostics, the nonvascular interventional radiology device market is expected to experience sustained growth, driven by advancements in orthopedic imaging and the overall modernization of healthcare infrastructure.
Market Dynamics
Several factors are driving the growth of the nonvascular interventional radiology device market:
- Technological Advancements: Rapid evolution in imaging technologies is enhancing diagnostic quality and efficacy, particularly in orthopedic imaging equipment. This technological infrastructure supports the integration of new devices and methodologies in clinical practice.
- Rising Incidence of Chronic Diseases: The increasing prevalence of conditions such as gastrointestinal disorders and cancer is driving demand for advanced diagnostic equipment, including nonvascular interventional devices.
- Consumer Preference for Minimally Invasive Treatments: There is a growing inclination among patients and healthcare providers towards minimally invasive procedures, which offer benefits such as reduced recovery times and lower complication rates.
Market Segmentation
The market can be segmented based on device type and application:
- Device Types: Includes puncture and drainage methods, as well as needle biopsy techniques, which are expected to hold a significant share due to their effectiveness in obtaining tissue samples with minimal invasion.
- Applications: Segmented into areas such as benign tumors, uterine fibroids, and liver and pancreatic conditions.
Competition Outlook
Key players in the nonvascular interventional radiology device industry occupy the competitive space, hindering the entry of new entrants. Owing to this force, new entrants need to invest more in product innovation and differentiation to embark on a stronger competitive position.
Leading manufacturers in the ecosystem, on the other hand, expand using many strategies, including collaborations, mergers, partnerships, and acquisitions. The collective ecosystem of such players drives the enlargement of the global nonvascular interventional radiology device market size.
- In April 2024, Hologic Inc. announced the acquisition of Endomagnetics Ltd. This move helped the organization in terms of diversification of reach within the market.
- In May 2024, Carestream Health Inc. launched an Image Suite MR 10 Software, aiming to elevate the imaging experience for CR and DR imaging systems.
Leading Nonvascular Interventional Radiology Device Brands
- Carestream Health Inc.
- Hologic Inc.
- GE Healthcare
- Fujifilm Corporation
- Samsung Healthcare (Samsung Electronics Co. Ltd.)
- Shimadzu Corporation
- Siemens Healthineers
- Canon Medical Systems Corporation
- Olympus Corporation
Nonvascular Interventional Radiology Device Market – Key Segments
By Type:
The ecosystem can be classified based on the device type into Puncture and Drainage Methods and Needle Biopsy.
By Application:
Based on the application, the sector can be segmented into Benign Tumors, Uterine Fibroids, and Live and pancreatic Conditions.
By Region:
North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and The Middle East and Africa are the key contributing regions to the industry.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
